Table 1 Patient characteristics
Patients (n = 9) | ||
|---|---|---|
Male/Female | 3/6 | |
Median Age (Range) | 63 (46–77) years | |
Disease stage | at diagnosis | at start of FCR |
I | 1 | 0 |
II | 1 | 5 |
III | 1 | 3 |
IV | 6 | 1 |
Bone marrow involvement | ||
0 % | 7 | |
10 % to ≤25 % | 2 | |
Extranodal involvement | 1 (liver) | |
FLIPI | ||
Low | 1 | |
Low-intermediate | 6 | |
Intermediate-high | 2 | |
Bulky disease | 1 | |
B-symptoms | 0 | |
Previous therapy including rituximab | ||
No | 2 | |
Yes | 7 | |
Number of previous regimens | ||
1 | 2 | |
2 | 5 | |
> 2 | 2 | |